BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 526430)

  • 1. The quantitative response of human tumours to radiation and misonidazole.
    Ash DV; Peckham MJ; Steel GG
    Br J Cancer; 1979 Dec; 40(6):883-9. PubMed ID: 526430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J; Hirst DG; Stewart FA; Terry NH
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of human tumour metastases to radiation and misonidazole.
    Dawen PJ; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
    Ydrach AA; Marcial VA; Parsons J; Concannon J; Asbell SO; George F
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):357-9. PubMed ID: 6809704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
    Schwade JG; Kinsella TJ; Kelly B; Rowland J; Johnston M; Glatstein E
    Cancer Invest; 1984; 2(2):91-5. PubMed ID: 6733563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
    Rofstad EK; Brustad T
    Acta Radiol Oncol; 1981; 20(4):261-5. PubMed ID: 6277155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
    Pedersen JE; Smith MR; Bugden RD; Peckham MJ
    Br J Cancer; 1979 Apr; 39(4):429-33. PubMed ID: 444398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental studies on radiosensitization of hypoxic cancer cells].
    Omura M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1972-80. PubMed ID: 6663130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
    Tamulevicius P; Bamberg M; Scherer E; Streffer C
    Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study.
    Meoz RT; Spanos WJ; Doss L; Johnson R; Wasserman TH
    Am J Clin Oncol; 1983 Aug; 6(4):417-22. PubMed ID: 6191560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
    Abratt RP
    Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K; Takahashi M; Dodo Y; Abe M
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract]   [Full Text] [Related]  

  • 17. Misonidazole & radiotherapy in the palliative treatment of lung cancer.
    Mameghan H; Heller EH
    Australas Radiol; 1983 Nov; 27(3):246-53. PubMed ID: 6202291
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of tumour size on radiosensitization by misonidazole.
    Stanley JA; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
    Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
    Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
    Thomlinson RH; Dische S; Gray AJ; Errington LM
    Clin Radiol; 1976 Apr; 27(2):167-74. PubMed ID: 776494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.